Effects of Pioglitazone and Metformin Combination Therapy on High-Molecular-Weight Adiponectin Compared With Metformin Monotherapy in Type 2 Diabetes Mellitus Patients

被引:0
|
作者
Matsushita, Takaya
Kaji, Akino
Kaji, Kuniaki
Takahashi, Eri
Usui, Takahiro
Asahi, Nobuteru
Sato, Tomoya
Ohono, Atushi
Ueki, Akio
机构
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
2490-PO
引用
收藏
页码:A626 / A626
页数:1
相关论文
共 50 条
  • [41] Effect of pioglitazone and metformin fixed-dose combination on hs-CRP and adiponectin in patients with type 2 diabetes
    Perez, A.
    Zhao, Z.
    Spanheimer, R.
    DIABETOLOGIA, 2009, 52 : S339 - S340
  • [42] Combination therapy for patients with Type 2 diabetes: repaglinide in combination with metformin
    Moses, Robert G.
    EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM, 2010, 5 (03) : 331 - 342
  • [43] Effect of Pioglitazone and Metformin Fixed-Dose Combination on hs-CRP and Adiponectin in Patients with Type 2 Diabetes
    Perez, Alfonso
    Zhao, Zhen
    Spanheimer, Robert
    DIABETES, 2009, 58 : A521 - A522
  • [44] The cost-effectiveness of pioglitazone in combination with metformin in the treatment of type 2 diabetes mellitus in Scotland
    Stynes, G
    Tilden, D
    Swift, M
    Cockle, S
    Haycox, A
    Aristides, M
    VALUE IN HEALTH, 2004, 7 (06) : 737 - 738
  • [45] The effects of pioglitazone and metformin on plasma visfatin levels in patients with treatment naive type 2 diabetes mellitus
    Erdem, Gokhan
    Dogru, Teoman
    Tasci, Ilker
    Bozoglu, Ergun
    Muhsiroglu, Ozlem
    Tapan, Serkan
    Ercin, Cemal Nuri
    Sonmez, Alper
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2008, 82 (02) : 214 - 218
  • [46] Long-term effects of pioglitazone and metformin on insulin sensitivity in patients with Type 2 diabetes mellitus
    Roden, M
    Laakso, M
    Johns, D
    Widel, M
    Urquhart, R
    Richardson, C
    Mariz, S
    Tan, MH
    DIABETIC MEDICINE, 2005, 22 (08) : 1101 - 1106
  • [47] Effects of Rosiglitazone/Metformin Fixed-Dose Combination Therapy and Metformin Monotherapy on Serum Vaspin, Adiponectin and IL-6 Levels in Drug-Naive Patients with Type 2 Diabetes
    Kadoglou, N. P. E.
    Kapelouzou, A.
    Tsanikidis, H.
    Vitta, I.
    Liapis, C. D.
    Sailer, N.
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2011, 119 (02) : 63 - 68
  • [48] Antithrombotic effects of rosiglitazone-metformin versus glimepiride-metformin combination therapy in patients with type 2 diabetes mellitus and metabolic syndrome
    Derosa, G
    Gaddi, AV
    Piccinni, MN
    Ciccarelli, L
    Salvadeo, S
    Peros, E
    Ghelfi, M
    Ferrari, I
    Cicero, AFG
    PHARMACOTHERAPY, 2005, 25 (05): : 637 - 645
  • [49] Pioglitazone alters fat distribution in patients with type 2 diabetes mellitus, in contrast to metformin
    Jacqueline T Jonker
    Rutger W van der Meer
    Luuk J Rijzewijk
    Lisa M Menting
    Michaela Diamant
    Johannes A Romijn
    Johannes WA Smit
    Albert de Roos
    Hildo J Lamb
    Journal of Cardiovascular Magnetic Resonance, 11 (Suppl 1)
  • [50] SAFETY AND EFFICACY OF SITAGLIPTIN COMPARED WITH GLIMEPIRIDE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS INADEQUATELY CONTROLLED WITH METFORMIN MONOTHERAPY
    Abrar, Amjad
    Khan, Shimal
    Rehman, Mehboob Ur
    Jan, Tehmina
    Faisal, Muhammad
    GOMAL JOURNAL OF MEDICAL SCIENCES, 2013, 11 (01): : 3 - 7